National and Kapodistrian University of Athens
Investigation of genetic and epigenetic factors in pediatric astrocytomas
Abstract
dc:descriptionHistone modifications are a major epigenetic mechanism of gene regulation, contributing to the growth and development of tumors. The histone methylation marks profile in pediatric astrocytomas and the involvement of histone modifications in tumor growth is currently understudied. In the present study, we investigated the global expression patterns of repressive H3K9me3, H3K27me3, H4K20me3 and active H3K4me3, H3K36me3 histone marks along with their corresponding enzymes SUV39H1, SETDB1, EZH2, MLL2, SETD2 in pediatric astrocytomas of different grades of malignancy and archival normal brain tissues. Bioinformatics analysis of databases was performed first and then the findings were further confirmed by immunohistochemistry and Western blotting. Then, we proceeded to examine the functional role of methyltransferases in cell viability and migration by using methylation inhibitors as well as gene silencing of SETDB1 and SUV39H1 with specific siRNAs in two pediatric GBM patient-derived cell lines (CHLA-200, SJ-GBM2). Differential expression of selected genes associated with epithelial-mesenchymal transition and apoptosis was then evaluated. Overexpression of histone methyltransferase genes and deregulation of the histone code in pediatric astrocytomas were detected, with higher levels of H4K20me3, H3K4me3, SUV39H1, SETDB1 and SETD2 compared to normal brain tissues. Pilocytic astrocytomas (Grade I) exhibited lower levels of the enzyme MLL2 compared to diffusely infiltrating tumors, indicating a different pattern of epigenetic regulation between the two types of astrocytic neoplasms. Ηigher expression of H3K9me3, H3K36me3 and SETDB1 expression was detected in grade IIΙ/IV astrocytomas compared to grade II. In univariate survival analysis, high H3K9me3, MLL2 and low SUV39H1 expression was associated with reduced patients’ disease-specific survival. Upon multivariate survival analysis, only SUV39H1 expression was revealed as an independent prognostic factor of adverse significance. Inhibition of SUV39H1 reduced cell viability and migration of pediatric glioblastomas in vitro. The differential biological role of SUV39H1 and SETDB1 methyltransferases was further investigated in high-grade astrocytomas where a higher expression of SETDB1, a positive correlation of the expression of the two methyltransferases with proneural genes and a negative correlation with mesenchymal genes was found in bioinformatics analysis. Gene silencing of SETDB1 and SUV39H1 in pHGG cell lines showed a significant reduction in cell viability and migration. SETDB1 silencing reversed epithelial-mesenchymal transition (EMT) by decreasing the expression of the transcription factor SNAI1 and increasing the expression of E-cadherin. At the same time, it reduced the expression levels of N-cadherin and the MARCKS gene. Suppression of SUV39H1 failed to reverse EMT but significantly reduced the expression of the above EMT genes. In addition, the silencing of SETDB1 significantly increased the levels of the anti-apoptotic gene BCL-2 and the bivalent tumor suppressor gene SLC17A7. Collectively, our data implicate high levels of H3K9me3 histone modification in pediatric astrocytoma pathology, high expression of SUV39H1 being a positive prognostic factor for low grade astrocytomas, and high expression of SETDB1 being a negative prognostic factor. In addition, SETDB1 plays an oncogenic role as it is associated with the development of high-grade tumors and the reduced prognosis of patients, while SUV39H1 mainly affects cell adhesion and apoptosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Klonou, Paraskevi-Alexia
- Κλώνου, Παρασκευή-Αλεξία
Subjects
dc:subject × 12Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52148